Re: ANDS results in genotype 1a vs. 1b HCV patients
What is the difference between genotype 1a and 1b HCV patients as far as market size? If the bulk of patients are 1a, I might be concerned as the drug was clearly more potent in the 1b type, although it was clearly active in 1a.
Still a difference between genotypes 1a and 1b but what looks strange here is that VL change was quite similar in genotype 1b and placebo 3.7 and 3.9 (log10 IU/ml) respectively.